BlackRock, Inc. 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Aquestive Therapeutics, Inc. AQST | BlackRock Inc. BLK | 5,823,077 6.400% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Aquestive Therapeutics, Inc. AQST | BlackRock Inc. BLK | 5,823,077 6.400% | 5,823,077 (New Position) | Filing |